BWAY · Brainsway Ltd.
$16.19
+1.18 (+7.86%)
At close · Aug 6
Market Cap
$602.37M
Shares
40.13M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$15.01
Open$15.77
Day$14.96–15.77
52W$5.70–17.35
Avg vol 30d119K
Short int172K · 0.4% float · 2.0d
Short vol53%
Last earningsMar 11, 2026
DataJan 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.46
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
−0%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
80%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+28%
trailing
YTD return
+58%
this year
Relative strength
+17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $15 › 200d $13 — 50d above 200d
Institutional flow
Distributing
16 of 56 funds reported for Jun 30 · net -39.9K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.43% of float · ▼ -6.4% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
56 holders — near 3-yr high, broad support
Squeeze score
32
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−19%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Sep 30, 2025
Revenue
· full year 2025
Raised
$51M – $52M
Adjusted EBITDA
· full year 2025
Raised
13% – 14%
Operating profit
· full year 2025
Initiated
6% – 7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
−0%
Neutral
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
80%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $15 › 200d $13 — 50d above 200d
Institutional flow
Distributing
16 of 56 funds reported for Jun 30 · net -39.9K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.43% of float · ▼ -6.4% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
56 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $6
Now $15 · 80%
52-wk high $17
vs 200-day avg +20%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BWAY
this stock
Brainsway Ltd.
|
$602.37M | +57.8% | — | — | 0.4% |
|
ABT
Abbott Laboratories
|
$184.13B | -14.1% | +5.7% | 29.6 | 1.4% |
|
SYK
Stryker Corp
|
$129.28B | -3.6% | +11.2% | 34.9 | 1.8% |
|
MDT
Medtronic plc
|
$110.07B | -8.9% | +8.4% | 23.1 | 1.5% |
|
BSX
Boston Scientific Corp
|
$69.19B | -49.9% | +5.5% | 19.3 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BWAY | +6.0% | +0.3% | +28.1% | -1.4% | +57.8% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | +0.5% | -2.9% | +16.9% | -4.5% | +44.9% |
Key facts
CIK
1505065
CUSIP
10501L106
13F (30d)
15 filings
14 filers
Visit website
Investor relations